PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 25239655-2 2014 NOS3 and NOS2 SNPs might modify plasma nitrite/nitrate (NOx) levels, sepsis development, hemodynamics and survival. nicotine 1-N-oxide 56-59 nitric oxide synthase 3 Homo sapiens 0-4 25320160-9 2015 CONCLUSION: We could replicate and extend previous findings showing altered NOx (-) levels in BPD and an influence of NOS3 rs2070744 on NOS3 expression and NOx (-) concentration. nicotine 1-N-oxide 76-79 nitric oxide synthase 3 Homo sapiens 118-122 25320160-9 2015 CONCLUSION: We could replicate and extend previous findings showing altered NOx (-) levels in BPD and an influence of NOS3 rs2070744 on NOS3 expression and NOx (-) concentration. nicotine 1-N-oxide 156-159 nitric oxide synthase 3 Homo sapiens 118-122 25239655-8 2014 Plasma NOx was higher in carriers of the T allele of the NOS3 (E298D) SNP (p = 0.006). nicotine 1-N-oxide 7-10 nitric oxide synthase 3 Homo sapiens 57-61 16007000-1 2005 OBJECTIVES: Controversy exists regarding the effects of polymorphisms in the endothelial nitric oxide synthase (eNOS) gene on nitrites/nitrates (NOx) plasma concentrations. nicotine 1-N-oxide 145-148 nitric oxide synthase 3 Homo sapiens 77-110 16007000-1 2005 OBJECTIVES: Controversy exists regarding the effects of polymorphisms in the endothelial nitric oxide synthase (eNOS) gene on nitrites/nitrates (NOx) plasma concentrations. nicotine 1-N-oxide 145-148 nitric oxide synthase 3 Homo sapiens 112-116 16007000-2 2005 In this study we compared the distribution of haplotypes involving three relevant eNOS polymorphisms (T-786C in the promoter region; b/a in intron 4, and Glu298Asp in exon 7) in healthy subjects with low and high circulating NOx levels. nicotine 1-N-oxide 225-228 nitric oxide synthase 3 Homo sapiens 82-86 16007000-10 2005 The frequencies of the remaining haplotypes were not different among group L and H. CONCLUSIONS: While eNOS genotypes are not significantly associated with changes in the circulating NOx concentrations, the specific eNOS haplotype that includes the "C", "4b", and "Glu" alleles is associated with lower circulating NOx concentrations. nicotine 1-N-oxide 315-318 nitric oxide synthase 3 Homo sapiens 216-220 11017941-3 2000 The aims of this study were to examine plasma NOx in patients with coronary artery disease (CAD) and to assess the association between plasma NOx concentrations and the three ecNOS gene polymorphisms. nicotine 1-N-oxide 142-145 nitric oxide synthase 3 Homo sapiens 175-180 9409304-6 1997 The results of the variance component linkage analysis were consistent with linkage of a quantitative trait locus in or near the ecNOS gene to variation in plasma NOx levels (P = .0066). nicotine 1-N-oxide 163-166 nitric oxide synthase 3 Homo sapiens 129-134 9409304-7 1997 While many environmental factors have been shown to alter transiently plasma NOx levels, our study is the first to identify a substantial effect of the ecNOS locus on the variance of plasma NOx, i.e. basal NO production. nicotine 1-N-oxide 77-80 nitric oxide synthase 3 Homo sapiens 152-157 9409304-7 1997 While many environmental factors have been shown to alter transiently plasma NOx levels, our study is the first to identify a substantial effect of the ecNOS locus on the variance of plasma NOx, i.e. basal NO production. nicotine 1-N-oxide 190-193 nitric oxide synthase 3 Homo sapiens 152-157 24944642-8 2014 In addition, the plasma NOx concentration in the eNOS Glu/Glu homozygote carriers (129.66+-59.15 mumol/l) was significantly lower compared with the Asp allele carriers (169.84+- 55.18 mumol/l; P=0.010). nicotine 1-N-oxide 24-27 nitric oxide synthase 3 Homo sapiens 49-53 24748593-2 2014 The present study was designed to evaluate the relationship between exercise training and NOS3 polymorphisms at -786T>C, 894G>T, and intron 4b/a on blood pressure (BP) using 24-h ambulatory BP monitoring (ABPM), nitrate/nitrite levels (NOx), and redox state. nicotine 1-N-oxide 242-245 nitric oxide synthase 3 Homo sapiens 90-94 24748593-10 2014 The NOS3 polymorphism for intron 4 mitigated the beneficial effect of ET for systolic BP (nonpolymorphic group: -3.0% and polymorphic group: -0.6%) and diastolic BP (nonpolymorphic group: -3.2% and polymorphic group: -0.5%), but it was not associated with NOx level and redox state. nicotine 1-N-oxide 256-259 nitric oxide synthase 3 Homo sapiens 4-8